Nestlé S.A. (NSRGY)

Other OTC - Other OTC Delayed Price. Currency in USD
79.02-0.58 (-0.73%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close79.60
Bid0.00 x
Ask0.00 x
Day's Range78.65 - 79.12
52wk Range68.00 - 83.25
1y Target EstN/A
Market Cap237.51B
P/E Ratio (ttm)27.46
Avg Vol (3m)460,056
Dividend & Yield2.32 (2.92%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters2 days ago

    Gut feeling: new CEO to steer Nestle down uncharted health path

    Using them to cure disease and boost wellness is one of several bets KitKat maker Nestle is making in the field of health and nutritional science, as it seeks to offset slowing sales of traditional processed foods. Ulf Mark Schneider, a German medical industry veteran, is expected to speed the drive into health-oriented products when he becomes the first Nestle outsider chief executive in nearly a century in January. Schneider's hiring from healthcare firm Fresenius signals Nestle's commitment to pioneering the interface of food and medicine, in part by focusing on nascent areas like microbiome therapy, which has potential to boost human health and Nestle's margins.

  • Reuters2 days ago

    Factbox: Nestle Health Science key investments

    Nestle believes its Health Science unit will eventually generate annual sales of 10 billion Swiss francs . It already has sales of more than 2 billion francs. Here are some of its recent deals: - Sept ...

  • The Wall Street Journal4 days ago

    Business Watch

    Business Watch